mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Hyaluronic Acid in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis with Emphasis on the Efficacy of Different Products

Colen S et al. – In the future it will be important to determine the exact mechanism of action of placebo as this may give us an idea of how to treat osteoarthritis more efficiently. Due to the limitations of this review (follow–up of just 3 months and large heterogeneity of the included studies), it is also important to compare the different hyaluronic acid (HA) products to determine which product(s), or which molecular weight range, concentration, or volume of HA is the best option to treat osteoarthritis. The authors' recommendation is to start large (multicenter) randomized controlled trials (RCTs) to give us more evidence about the efficacy of the different HA products.

Methods
  • A systematic review of randomized controlled trials (RCTs) was conducted using databases including MEDLINE, Cochrane Database of Systematic Reviews, Cochrane Clinical Trial Register and EMBASE.
  • Seventy–four RCTs were included in this systematic review.

Results
  • HA improves pain by approximately 40–50% compared with baseline levels.
  • However, when compared with saline the difference in efficacy is not that large.
  • Due to a large ‘placebo effect’ of saline (approximately 30% pain reduction, persisting for at least 3 months) the authors determined a weighted mean difference between the efficacy of HA and saline of just 10.20 using the visual analog scale for pain.
  • It is debatable whether this difference reaches the minimum clinically important difference.
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close